<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">cardiovascular</journal-id><journal-title-group><journal-title xml:lang="ru">Кардиоваскулярная терапия и профилактика</journal-title><trans-title-group xml:lang="en"><trans-title>Cardiovascular Therapy and Prevention</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1728-8800</issn><issn pub-type="epub">2619-0125</issn><publisher><publisher-name>«SILICEA-POLIGRAF» LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15829/1728-8800-2018-4-19-25</article-id><article-id custom-type="elpub" pub-id-type="custom">cardiovascular-606</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОСТРЫЙ КОРОНАРНЫЙ СИНДРОМ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ACUTE CORONARY SYNDROME</subject></subj-group></article-categories><title-group><article-title>Основные предикторы госпитальных неблагоприятных исходов у пациентов с острым коронарным синдромом без подъема сегмента ST при многососудистом поражении коронарного русла</article-title><trans-title-group xml:lang="en"><trans-title>Main predictors of in-hospital adverse outcomes in non-ST elevation acute coronary syndrome patients  with multivessel disease</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7016-0518</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Неверова</surname><given-names>Ю. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Neverova</surname><given-names>Yu. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Неверова Юлия Николаевна — врач, сердечно-сосудистый хирург кардиохирургического отделения,</p><p>Кемерово, +7 (923) 517-53-06</p></bio><bio xml:lang="en"><p>Kemerovo</p></bio><email xlink:type="simple">yuli4cka.n@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3882-709X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Тарасов</surname><given-names>Р. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Tarasov</surname><given-names>R. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Тарасов Роман Сергеевич — доктор медицинских наук, заведующий лабораторией реконструктивной хирургии мультифокального атеросклероза.</p><p>Кемерово</p></bio><bio xml:lang="en"><p>Kemerovo</p></bio><email xlink:type="simple">roman.tarasov@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4361-9853</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Нагирняк</surname><given-names>О. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Nagirnyak</surname><given-names>O. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Нагирняк Ольга Алексеевна — кандидат медицинских наук, врач, кардиолог отделения интервенционных методов диагностики и лечения.</p></bio><bio xml:lang="en"><p>Kemerovo</p></bio><email xlink:type="simple">nagirnyak.o@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБНУ Научно-исследовательский институт комплексных проблем сердечно-сосудистых  заболеваний</institution></aff><aff xml:lang="en"><institution>Research Institute for Complex Issues of Cardiovascular Diseases</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2018</year></pub-date><pub-date pub-type="epub"><day>20</day><month>08</month><year>2018</year></pub-date><volume>17</volume><issue>4</issue><fpage>19</fpage><lpage>25</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Неверова Ю.Н., Тарасов Р.С., Нагирняк О.А., 2018</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="ru">Неверова Ю.Н., Тарасов Р.С., Нагирняк О.А.</copyright-holder><copyright-holder xml:lang="en">Neverova Y.N., Tarasov R.S., Nagirnyak O.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://cardiovascular.elpub.ru/jour/article/view/606">https://cardiovascular.elpub.ru/jour/article/view/606</self-uri><abstract><sec><title>Цель</title><p>Цель. Оценить комплекс факторов риска, ассоциированных с возникновением неблагоприятных кардиоваскулярных событий в госпитальном периоде наблюдения у пациентов с острым коронарным синдромом без подъема сегмента ST (ОКС↓ST) с многососудистым поражением (МП) коронарного русла.</p></sec><sec><title>Материал и методы</title><p>Материал и методы. В исследование в рамках проспективного, одноцентрового регистра были включены пациенты с ОКС↓ST и МП коронарного русла. В зависимости от реализованной стратегии реваскуляризации были сформированы три группы исследования: поэтапное чрескожное коронарное вмешательство (ЧКВ), коронарное шунтирование (КШ), первый этап ЧКВ и второй этап КШ. Под неблагоприятными кардиоваскулярными событиями понимали смерть, инфаркт миокарда, острое нарушение мозгового кровообращения/транзиторная ишемическая атака, клинически значимое кровотечение по шкале BARC, повторная незапланированная реваскуляризация целевого сосуда.</p></sec><sec><title>Результаты</title><p>Результаты. По результатам анализа группами факторов, увеличивающими вероятность развития неблагоприятных кардиоваскулярных событий, стали такие, как: (1) клинико-демографические: пожилой возраст, сахарный диабет, постинфарктный кардиосклероз, мультифокальный атеросклероз, хроническая почечная недостаточность; (2) коронарные и хирургические: поражение ствола левой коронарной артерии, высокая выраженность коронарного атеросклероза по шкале SYNTAX Score, высокие показатели хирургического риска по шкале EuroScore II, выбранная стратегия реваскуляризации; (3) преобладание низкого и  промежуточного риска по шкале GRACE по сравнению с высоким риском.</p></sec><sec><title>Заключение</title><p>Заключение. Полученные результаты подтвердили высокую прогностическую значимость клинико-демографических и коронарных факторов для развития неблагоприятных кардиоваскулярных событий. Важной находкой настоящего исследования стал факт, свидетельствующий о том, что в условиях кардиохирургической клиники, располагающей возможностью выполнения эндоваскулярной и хирургической реваскуляризации миокарда в режиме 24/7, наличие промежуточного и низкого риска по шкале GRACE у пациентов с ОКС↓ST при МП является фактором развития неблагоприятных кардиоваскулярных событий вследствие задержки реваскуляризации в отсутствии высокого риска.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Aim</title><p>Aim. To evaluate the range of risk factors associated with adverse cardiovascular events onset in hospital period of follow-up in patients with non-ST elevation acute coronary syndrome (NSTEACS) with multivessel disease (MD).</p></sec><sec><title>Material and methods</title><p>Material and methods. To the study, under the framework of prospective, single-center registry, the NSTEACS and MD patients were included. Depending on the strategy of revascularization, three groups were selected: staged PCI, coronary bypass (CBG) and PCI as the first with CBG as the second stage. As adverse cardiovascular events, the following were taken: death, myocardial infarction, stroke or transient cerebral ishemia, clinically significant bleeding by BARC, repeat nonscheduled revascularization of target vessel. </p></sec><sec><title>Results</title><p>Results. Analysis revealed the groups of factors increasing the probability of adverse cardiovascular events. Those are: (1) clinical and demographic  — older age, diabetes, postinfarction cardiosclerosis, multifocal atherosclerosis, chronic renal failure; (2) coronary and surgical — left main stem lesion, severe atherosclerosis by SYNTAX Score, high surgical risk by EuroScore II, revascularization strategy;  (3) predominance of low or moderate risk by GRACE comparing with high risk.</p></sec><sec><title>Conclusion</title><p>Conclusion. The results have confirmed high predictional significance of clinical and demography and coronary factors for development of adverse cardiovascular diseases. A significant finding of the study was the fact that in a hospital with surgery and endovascular treatment available 24/7, the intermediate and low GRACE risk in NSTEACS and MD is a factor of adverse cardiovascular events development due to revascularization delays if the risk is not high.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>острый коронарный синдром без подъема сегмента ST</kwd><kwd>многососудистое поражение</kwd><kwd>чрескожное коронарное вмешательство</kwd><kwd>коронарное шунтирование</kwd><kwd>стратегия реваскуляризации</kwd><kwd>факторы неблагоприятных исходов</kwd></kwd-group><kwd-group xml:lang="en"><kwd>non-ST elevation acute coronary syndrome</kwd><kwd>multivessel disease</kwd><kwd>percutaneous coronary intervention</kwd><kwd>coronary bypass grafting</kwd><kwd>revascularization strategy</kwd><kwd>adverse outcomes factors</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Yeh RW, SidneyS. Population trends in the incidence and outcomes of acute myocardial infarction. New England Journal of Medcine. 2010;362(23):2155-65. doi:10.1056/NEJMoa0908610.</mixed-citation><mixed-citation xml:lang="en">Yeh RW, SidneyS. Population trends in the incidence and outcomes of acute myocardial infarction. New England Journal of Medcine. 2010;362(23):2155-65. doi:10.1056/NEJMoa0908610.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Chang M, Lee CW, Ahn JM. Predictors of long-term outcomes after bypass grafting versus drug-eluting stent implantation for left main or multivessel coronary artery disease.Catheter Cardiovasc Interv. 2017;1;90(2):177-85. doi:10.1002/ccd.26927.</mixed-citation><mixed-citation xml:lang="en">Chang M, Lee CW, Ahn JM. Predictors of long-term outcomes after bypass grafting versus drug-eluting stent implantation for left main or multivessel coronary artery disease.Catheter Cardiovasc Interv. 2017;1;90(2):177-85. doi:10.1002/ccd.26927.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Gnavi R, Rusciani R. Gender, socioeconomic position, revascularization procedures and mortality in patients presenting with STEMI and NSTEMI in the era of primary PCI. Differencesorinequities? Int J Cardiol. 2014;176(3):724-30. doi:10.1016.</mixed-citation><mixed-citation xml:lang="en">Gnavi R, Rusciani R. Gender, socioeconomic position, revascularization procedures and mortality in patients presenting with STEMI and NSTEMI in the era of primary PCI. Differencesorinequities? Int J Cardiol. 2014;176(3):724-30. doi:10.1016.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Fukui T, Tabata M. Early and long-term outcomes of coronary artery bypass grafting and percutaneous coronary intervention in patients with left main disease: singlecenter results of multidisciplinary decision making. Gen Thorac Cardiovasc Surg. 2014;62(5):301-7. doi:10.1007/s11748.</mixed-citation><mixed-citation xml:lang="en">Fukui T, Tabata M. Early and long-term outcomes of coronary artery bypass grafting and percutaneous coronary intervention in patients with left main disease: singlecenter results of multidisciplinary decision making. Gen Thorac Cardiovasc Surg. 2014;62(5):301-7. doi:10.1007/s11748.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Bangalore S, Toklu B, Feit F. Outcomes with coronary artery bypass graft surgery versus percutaneous coronary intervention for patientswith diabetes mellitus: can newer generation drug-eluting stents bridge the gap? Circ Cardiovasc Interv. 2014;7(4):518-25. doi:10.1161/CIRCINTERVENTIONS.114.001970.</mixed-citation><mixed-citation xml:lang="en">Bangalore S, Toklu B, Feit F. Outcomes with coronary artery bypass graft surgery versus percutaneous coronary intervention for patientswith diabetes mellitus: can newer generation drug-eluting stents bridge the gap? Circ Cardiovasc Interv. 2014;7(4):518-25. doi:10.1161/CIRCINTERVENTIONS.114.001970.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Sargin M, Tatlisu MA, Mete MT. Stent versus bypass: The reasons and risk factors for early readmission to hospital after myocardial revascularization. North ClinIstanb. 2016;3(1):27-33. doi:10.14744/nci.2016.43434.</mixed-citation><mixed-citation xml:lang="en">Sargin M, Tatlisu MA, Mete MT. Stent versus bypass: The reasons and risk factors for early readmission to hospital after myocardial revascularization. North ClinIstanb. 2016;3(1):27-33. doi:10.14744/nci.2016.43434.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Zheng Z, Xu B, Zhang H, Guan C. Coronary Artery Bypass Graft Surgery and Percutaneous Coronary Interventions in Patients With Unprotected Left Main Coronary Artery Disease. JACC CardiovascInterv. 2016;9(11):1102-11. doi:10.1016/j.jcin.2016.03.039.</mixed-citation><mixed-citation xml:lang="en">Zheng Z, Xu B, Zhang H, Guan C. Coronary Artery Bypass Graft Surgery and Percutaneous Coronary Interventions in Patients With Unprotected Left Main Coronary Artery Disease. JACC CardiovascInterv. 2016;9(11):1102-11. doi:10.1016/j.jcin.2016.03.039.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Bundhun PK, Wu ZJ, Chen MH. Coronary artery bypass surgery compared with percutaneous coronary interventions in patients with insulin-treated type 2 diabetes mellitus: a systematic review and meta-analysis of 6 randomized controlled trials. Cardiovasc Diabetol. 2016;15(2):1105 -09. doi:10.1186/s12933-015-0323-z.</mixed-citation><mixed-citation xml:lang="en">Bundhun PK, Wu ZJ, Chen MH. Coronary artery bypass surgery compared with percutaneous coronary interventions in patients with insulin-treated type 2 diabetes mellitus: a systematic review and meta-analysis of 6 randomized controlled trials. Cardiovasc Diabetol. 2016;15(2):1105 -09. doi:10.1186/s12933-015-0323-z.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Collet CJ-Ph, Mueller Ch, Roffi M, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2015;831-72. doi:10.1093/eurheartj/ehv320.</mixed-citation><mixed-citation xml:lang="en">Collet CJ-Ph, Mueller Ch, Roffi M, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2015;831-72. doi:10.1093/eurheartj/ehv320.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Cavalcante R, Sotomi Y, Lee CW. OutcomesAfter Percutaneous Coronary Intervention or Bypass Surgery in Patients With Unprotected Left Main Disease. JACC. 2016;68(10):999-1009. doi:10.1016/j.jacc.2016.06.024.</mixed-citation><mixed-citation xml:lang="en">Cavalcante R, Sotomi Y, Lee CW. OutcomesAfter Percutaneous Coronary Intervention or Bypass Surgery in Patients With Unprotected Left Main Disease. JACC. 2016;68(10):999-1009. doi:10.1016/j.jacc.2016.06.024.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Pereg D, Fefer P, Samuel M. Long-term Follow-up of Coronary Artery Bypass Patients With Preoperative and New Postoperative Native Coronary Artery Chronic Total Occlusion. Can J Cardiol. 2016;32(11):1326-31. doi:10.1016/j.cjca.2016.01.015.</mixed-citation><mixed-citation xml:lang="en">Pereg D, Fefer P, Samuel M. Long-term Follow-up of Coronary Artery Bypass Patients With Preoperative and New Postoperative Native Coronary Artery Chronic Total Occlusion. Can J Cardiol. 2016;32(11):1326-31. doi:10.1016/j.cjca.2016.01.015.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Ueki C, Miyata H, Motomura N. Previous Percutaneous Coronary Intervention Does Not Increase Adverse Events After Coronary Artery Bypass Surgery. Ann Thorac Surg. 2017;pii:S0003-4975(16)31477-1. doi:10.1016/j.athoracsur.2016.10.028. [Epub ahead of print].</mixed-citation><mixed-citation xml:lang="en">Ueki C, Miyata H, Motomura N. Previous Percutaneous Coronary Intervention Does Not Increase Adverse Events After Coronary Artery Bypass Surgery. Ann Thorac Surg. 2017;pii:S0003-4975(16)31477-1. doi:10.1016/j.athoracsur.2016.10.028. [Epub ahead of print].</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Bundhun PK, Pursun M, Teeluck AR. Adverse Cardiovascular Outcomes associated with Coronary Artery Bypass Surgery and Percutaneous Coronary Intervention with Everolimus Eluting Stents: A Meta-Analysis. SciRep. 2016;6:35869. doi:10.1038/srep35869.</mixed-citation><mixed-citation xml:lang="en">Bundhun PK, Pursun M, Teeluck AR. Adverse Cardiovascular Outcomes associated with Coronary Artery Bypass Surgery and Percutaneous Coronary Intervention with Everolimus Eluting Stents: A Meta-Analysis. SciRep. 2016;6:35869. doi:10.1038/srep35869.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Luthra S, LeivaJuárez MM. Percutaneous Intervention Before Coronary Artery Bypass Surgery Does Not Unfavorably Impact Survival: A Single-Center PropensityMatched Analysis. Ann Thorac Surg. 2016;102(6):1911-8. doi:10.1016/j.athoracsur.2016.07.046.</mixed-citation><mixed-citation xml:lang="en">Luthra S, LeivaJuárez MM. Percutaneous Intervention Before Coronary Artery Bypass Surgery Does Not Unfavorably Impact Survival: A Single-Center PropensityMatched Analysis. Ann Thorac Surg. 2016;102(6):1911-8. doi:10.1016/j.athoracsur.2016.07.046.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Parikh SV, de Lemos JA, Jessen ME, et al. Timing of in-hospital coronary artery bypass graft surgery for non-ST-segment elevation myocardial infarction patients results from the National Cardiovascular Data Registry ACTION Registry-GWTG (Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With The Guidelines). JACC: Cardiovasc Interv. 2010;3(4):419-27. doi:10.1016/j.jcin.2010.01.012.</mixed-citation><mixed-citation xml:lang="en">Parikh SV, de Lemos JA, Jessen ME, et al. Timing of in-hospital coronary artery bypass graft surgery for non-ST-segment elevation myocardial infarction patients results from the National Cardiovascular Data Registry ACTION Registry-GWTG (Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With The Guidelines). JACC: Cardiovasc Interv. 2010;3(4):419-27. doi:10.1016/j.jcin.2010.01.012.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
